Biotech & Pharma

Innovus Pharmaceuticals got a dose of testosterone in its share price this week. The over-the-counter and consumer products for men’s and women’s health announced that it had recently acquired Beyond Human for a cash purchase price of $630,000. The acquisition provided the company with natural testosterone booster supplements, including Beyond T Human® and Human Growth … Continue reading “Innovus Pharmaceuticals (OTC: INNV) Grows Balls With Testosterone Supplement Acquisition”